Blockbuster weight-loss drug Wegovy is losing market share in the U.S. Here’s why
Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy obesity drug, as it battled pressure from compounding pharmacies in…











